Esprit Recall Notification Delay To Blame For Respironics’ FDA Warning
This article was originally published in The Gray Sheet
Executive Summary
Respironics' failure to notify FDA within 10 days of a recall involving Esprit ventilator check valves was the catalyst for a recent warning letter to the firm